Lakefront Biotherapeutics NV
LKFT- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001421876
No open-market purchases or sales by Lakefront Biotherapeutics NV insiders were filed in the last 90 days; 76 institutions reported holding it in 13F filings for Q2 2026, worth $960.3M in total; Greenlight Capital is the only superinvestor holding it.
Other share classesGLPGF
Q1 2024 vs. Q4 2023
How the institutions holding Lakefront Biotherapeutics NV changed between Q4 2023 and Q1 2024.
All holders in Q1 2024All holders in Q4 2023
| Measure | Q4 2023 | Of which not filed for Q1 2024 | Q1 2024 | Change |
|---|---|---|---|---|
| Holders | 88 | 1 | 83 | −4 |
| Shares | 19.8M | 162.6K | 20.5M | +858.5K (+4.4%) |
| Value | $804.5M | $6.61M | $659.6M | −$138.2M (−17.3%) |
1 institution that held it in Q4 2023 haven't filed for Q1 2024 yet. Not filing isn't selling, so the changes leave them out.
New holders (9)
Institutions that held Lakefront Biotherapeutics NV at the end of Q1 2024 but not at the end of Q4 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| DME Capital Management, LPSuperinvestorGreenlight Capital | 159,828 | $5.15M | 0.24% |
| Wells Fargo & Company | 432 | $13.9K | 0.00% |
| Rise Advisors, LLC | 425 | $13.7K | 0.01% |
| Simplex Trading, LLC | 385 | $12.0K | 0.00% |
| EverSource Wealth Advisors, LLC | 130 | $3.70K | 0.00% |
| RFP Financial Group LLC | 68 | $2.19K | 0.00% |
| The PNC Financial Services Group, Inc. | 63 | $2.03K | 0.00% |
| Principal Securities, Inc. | 48 | $1.55K | 0.00% |
| Harbor Investment Advisory, LLC | 4 | $129 | 0.00% |
Sold out (13)
Institutions that held Lakefront Biotherapeutics NV at the end of Q4 2023 and filed for Q1 2024 without it.
| Institution | Shares, Q4 2023 | Value, Q4 2023 |
|---|---|---|
| Jane Street Group, LLC | 42,682 | $1.74M |
| Old Mission Capital LLC | 33,980 | $1.38M |
| HighVista Strategies LLC | 12,953 | $526.5K |
| Bank of Montreal | 11,566 | $473.9K |
| Walleye Capital LLC | 8,998 | $365.8K |
| GTS Securities LLC | 8,563 | $348.1K |
| Prelude Capital Management, LLC | 6,684 | $271.7K |
| Cutler Group LP | 345 | $14.0K |
| Point72 Hong Kong Ltd | 300 | $12.2K |
| Planned Solutions, Inc. | 100 | $4.07K |
| WealthCollab, LLC | 100 | $4.07K |
| Ronald Blue Trust, Inc. | 106 | $4.00K |
| Clear Street Markets LLC | 46 | $2.00K |
Not filed for Q1 2024 yet (1)
Institutions that held Lakefront Biotherapeutics NV at the end of Q4 2023 and haven't filed a 13F for Q1 2024. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q4 2023 | Value, Q4 2023 |
|---|---|---|
| Greenlight Capital Inc | 162,578 | $6.61M |